Neurological immune-related adverse events of immune checkpoint inhibitors: clinical and hematological risk factors
{{output}}
Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but can induce neurological immune-related adverse events (n-irAEs). Objecti... ...
